Israel I. Olayide, Elise Stuertz, Nick Latzo, Robert Devine, Vanja Kalajdzic, Angelina Ellis et al. Cinnamyl-driven GPR183 antagonists: Scaffold optimization toward non-opioid pain therapy. // European Journal of Medicinal Chemistry Reports. – 2026. – DOI: 10.1016/j.ejmcr.2026.100373. – URL: https://doi.org/10.1016/j.ejmcr.2026.100373
Israel I. Olayide, Elise Stuertz, Nick Latzo, Robert Devine, Vanja Kalajdzic, Angelina Ellis, Joanna Gongora, Ivy Yang, Varin Gupta, Dietrich Olibrice, Olivia Farris, Kyle Oberkrom, Kathryn Braen-McInerney, Daniela Salvemini, & Christopher Arnatt (2026). Cinnamyl-driven GPR183 antagonists: Scaffold optimization toward non-opioid pain therapy. European Journal of Medicinal Chemistry Reports. https://doi.org/10.1016/j.ejmcr.2026.100373
Israel I. Olayide, et al. “Cinnamyl-driven GPR183 antagonists: Scaffold optimization toward non-opioid pain therapy.” European Journal of Medicinal Chemistry Reports, 2026. doi:10.1016/j.ejmcr.2026.100373.
@article{Olayide2026,
title = {Cinnamyl-driven GPR183 antagonists: Scaffold optimization toward non-opioid pain therapy},
author = {Olayide, Israel I. and Stuertz, Elise and Latzo, Nick and Devine, Robert and Kalajdzic, Vanja and Ellis, Angelina and Gongora, Joanna and Yang, Ivy and Gupta, Varin and Olibrice, Dietrich and Farris, Olivia and Oberkrom, Kyle and Braen-McInerney, Kathryn and Salvemini, Daniela and Arnatt, Christopher},
journal = {European Journal of Medicinal Chemistry Reports},
year = {2026},
doi = {10.1016/j.ejmcr.2026.100373},
url = {https://doi.org/10.1016/j.ejmcr.2026.100373}
}